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SIRT1 is a NAD+-dependent deacetylase that
governs a number of genetic programs to cope
with changes in the nutritional status of cells and
organisms. Behavioral responses to food abundance
are important for the survival of higher animals. Here
we used mice with increased or decreased brain
SIRT1 to show that this sirtuin regulates anxiety
and exploratory drive by activating transcription of
the gene encoding the monoamine oxidase A
(MAO-A) to reduce serotonin levels in the brain.
Indeed, treating animals with MAO-A inhibitors or
selective serotonin reuptake inhibitors (SSRIs)
normalized anxiety differences between wild-type
and mutant animals. SIRT1 deacetylates the brain-
specific helix-loop-helix transcription factor NHLH2
on lysine 49 to increase its activation of the MAO-A
promoter. Both common and rare variations in the
SIRT1 gene were shown to be associated with risk
of anxiety in human population samples. Together
these data indicate that SIRT1 mediates levels of
anxiety, and this regulation may be adaptive in
a changing environment of food availability.
INTRODUCTION
Anxiety is an emotional response to a perceived threat or chal-
lenge. This response is crucial for learning, memory formation,
adaptation to the environment, and ultimately survival. Inability
to regulate these emotional responses leads to various mental
disorders. It is estimated that in a given year almost 26%
of Americans age 18 or older suffer from a diagnosable
mental disorder, many of which are various forms of anxiety
(Kessler et al., 2005). Therapeutic treatment of depressionCand anxiety disorders can be achieved by increasing the avail-
ability of serotonin and norepinephrine in the brain. A number of
drugs have been developed for this purpose to inhibit mono-
amine oxidases (MAOIs) as well as to inhibit serotonin reuptake
(SSRIs).
SIRT1 is an NAD-dependent protein deacetylase that was
shown to play a role in numerous metabolic processes in many
tissues, including brain (Chen et al., 2008). For example, SIRT1
was recently shown to act in the brain to reduce the production
of Ab amyloid peptide and ameliorate symptoms in a murine
Alzheimer’s disease model (Donmez et al., 2010). Two laborato-
ries have also reported that SIRT1 affects learning and memory
(Gao et al., 2010; Micha´n et al., 2010).
Here we report the investigation of the role of brain SIRT1 on
mood and behavior. Our findings suggest amechanistic relation-
ship between anxiety and SIRT1 levels in the brain, which are
driven by the deacetylation of a transcription factor regulating
the monoamine oxidase A gene. Our results indicate that manip-
ulation of brain SIRT1 activity may affect human mood in
a predictable way, which may aid and encourage development
of sirtuin drugs that cross the blood brain barrier.
RESULTS
SIRT1 Mutant Mice Have Altered Anxiety
and Exploratory Drive
To evaluate the global impact of SIRT1 on brain physiology, we
compared microarray gene expression profiles of brain tissues
from brain-specific SIRT1 knockout mice (BSKO), which have
the catalytic domain of this sirtuin (exon 4) deleted in the nervous
system (Cohen et al., 2009) (Figure 1A), to those of wild-type (WT)
littermates (NCBI accession number: GSE28790; Figures S1A–
S1G and Table S1 available online). One of the most overrepre-
sented categories of genes (as classified by the Gene Ontology
database) (Ashburner et al., 2000) was one that determines
behavior, specifically locomotor behavior and stress responses
(Table S1).ell 147, 1459–1472, December 23, 2011 ª2011 Elsevier Inc. 1459
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Figure 1. SIRT1 Affects Anxiety and Exploratory
Drive
(A) BSKO mice that lack functional SIRT1 in the brain
(these mice have exon 4 of SIRT1 deleted specifically in
the brain) have lower levels of MAO-A, as shown by SDS-
PAGE (top panel). Other tissues such as liver have normal
SIRT1 (middle panel). Transgenic mice that overexpress
SIRT1 in the brain (Sirt1 OX) have higher levels of MAO-A
(lower panel). Typical SDS-PAGE blots of SIRT1 and
MAO-A are presented here.
(B) Zero-maze test for anxiety and exploratory drive in
rodents. Mice are naturally afraid of open spaces and
prefer to be next to a wall or in an enclosed area. The
fraction of time the animal spends in the open arms of the
maze is indicative of the exploratory drive and anxiety of
that animal.
(C) BSKO mice are less anxious and have enhanced
exploratory drive, and this difference can be normalized
by the MAOI phenelzine. Also see Figures S1K and S1L.
Mean ± SEM is shown.
(D) SIRT1 OX mice have diminished exploratory drive, and
this difference can be normalized by phenelzine. Also see
Figure S1M. Mean ± SEM is shown.
(E) BSKO mice explore more and SIRT1 OX mice explore
less than their littermates in open-field test paradigm. Also
see Figure S1N. Mean ± SEM is shown.
(F and G) BSKO and SIRT1 OX mice have similar activity
during anxiety tests as their WT littermates. Digital videos
of mice during corresponding tests (F—zero-maze, G—
open-arena test) were analyzed, and distance traveled for
each mouse was established. Box-plots and individual
data points are presented here. Whiskers of box-plots
represent 5%–95% data span. Box-plots present median,
25th, and 75th percentiles of data.
(H) BSKO mice are less susceptible to depression and
anhedonia following a social defeat.Mean±SEM is shown.
(I–L) BSKO mice are resistant to depression, and SIRT1
OXmice are more susceptible. (I) BSKOmice are resistant
to depression in Porsolt’s test (spend less time floating);
these differences can be normalized (J) by phenelzine. (K)
SIRT1 OX mice are more susceptible to depression, and
this difference can be normalized (L) by phenelzine.
Data presented as mean ± SEM. p values are calculated
using t test (in surface plots, area is used for p value
calculation; Figures S1L–S1N contain complete statistical
analysis of the data presented).Based on these observations, we performed a number of
specific tests to study the behavior of mice with altered SIRT1
levels in the brain. The first of these, the zero-maze, is a test
designed to assess the exploratory drive of animals as well as
their levels of anxiety (Shepherd et al., 1994). Mice are naturally
anxious in open spaces and prefer to be next to a wall or in an
enclosed area. Zero-maze consists of a circular, raised platform,
two quadrants of which are protected and two quadrants of
which are open (Figure 1B). Mice are filmed while in the maze,
and their behavior is analyzed. BSKO mice explored the open
arms of the radial maze almost twice as much as their WT litter-
mates (Figures 1C and S1L). A similar anxiolytic effect and
increase in exploration were achieved pharmacologically. Phe-
nelzine, a drug that inhibits MAO enzymes (Figure 1C), and fluox-
etine, a serotonin reuptake inhibitor (Figure S1K), enhanced
exploratory drive of WT mice to the level of BSKO mice but did
little to the already overactive behavior of BSKO mice. This1460 Cell 147, 1459–1472, December 23, 2011 ª2011 Elsevier Inc.experiment suggested that the difference in behavior of BSKO
mice is unlikely to be due to some physical difference, such as
muscle strength, because mood-modifying drugs could
normalize exploratory behaviors. Additionally, these results
provided an initial suggestion that SIRT1 affects behavior by
altering serotonin levels in the brain. Interestingly, one of the
genes that was identified by microarray analysis to have
decreased expression in the brains of BSKO mice (Figure S1C)
was monoamine oxidase A (MAO-A), which encodes an enzyme
that regulates availability of serotonin in the brain.
Conversely, we found that SIRT1-overexpressing mice (SIRT1
OXmice) (Bordone et al., 2007), which have about twice asmuch
brain SIRT1 protein as control mice (Figures 1A and S1J), had
lower levels of exploratory drive compared to their WT litter-
mates (Figures 1D and S1M). Similarly, treatment with phenel-
zine equalized the exploratory drive of transgenic mice and their
WT littermates (Figures 1D and S1M), again indicating that
differences in behavior evoked by SIRT1 dosage are driven by
psychological changes.
Another assay for anxiety and exploration is the open-field test
(Cunha and Masur, 1978), in which mice are put into a large
circular arena, surrounded by walls. Anxiety in open spaces
will force mice to spend most of their time next to the border of
the arena. The fraction of time the mice spend exploring the
center of the arena versus the edges can be used for quantifica-
tion of rodent anxiety and exploratory drive. As with zero-maze
tests, we found that BSKO mice spent more time in the center,
demonstrating less anxiety-like behaviors and more exploratory
drive than their WT littermates (Figure 1E). Conversely, SIRT1 OX
mice displayed more anxious behavior compared to control
littermates (Figures 1E and S1N).
We previously reported that BSKO mice have elevated phys-
ical activity (Cohen et al., 2009), when measured by a free
running wheel experiment. Therefore, we assessed the activity
of BSKO mice, SIRT1 OX mice, and their WT littermates by
measuring their average distance traveled in both zero-maze
(Figure 1F) and open-field tests (Figure 1G) and found no statis-
tically significant differences. Thus, when mice with altered
SIRT1 are introduced into a novel environment, their physical
activity is not changed compared toWT, therefore corroborating
that altered behavior of these transgenic mice is independent of
their physical activity.
Anxiety often manifests accompanied by depression. We
therefore used the ‘‘social defeat’’ paradigm and the Porsolt’s
test (forced swim test) to measure susceptibility of animals to
depression. In the social defeat paradigm, the state of depres-
sion is induced in experimental male subjects after repeated
exposure to stronger, more aggressive dominant males. Socially
defeatedmales exhibit a number of changes in their behavior and
physiology (Von Frijtag et al., 2000), including anhedonia, amani-
festation of depression-like symptoms measured by decrease in
preference of a sucrose solution over normal drinking water. We
subjected WT and BSKO mice to social defeat and found that
SIRT1 BSKO mice were more resistant to depression than their
WT littermates (Figure 1H). This study must be interpreted with
caution, as BSKO mice had a somewhat lower baseline prefer-
ence for sucrose, which could be explained by alterations in their
metabolism (Cohen et al., 2009), taste, or olfaction.
In the forced swim test, naive mice are placed into a tall
cylinder filled half-way with water, where they will swim around
and try to find an escape by attempting high jumps, a behavior
called ‘‘struggle.’’ Over time, however, mice cease their attempts
to escape and float passively, indicative of a depression-like
state. BSKOmicewere less susceptible to depression (Figure 1I),
as they attempted escape more often and spent less time
floating. Pharmacological inhibition of MAO enzymes by phenel-
zine normalized behavior of BSKOs and their WT littermates
(Figure 1J). Conversely, SIRT1 OX mice were more susceptible
to depression (Figure 1K), and again phenelzine treatment
normalized their behavior (Figure 1L).
We hypothesized that the SIRT1 effect on behavior might be
mediated by changes in the levels of serotonin and perhaps
other neurotransmitters that affect anxiety (Nordquist and
Oreland, 2010). Thus we performed high-pressure liquid chro-
matography (HPLC) analysis of whole brains and quantifiedCconcentrations of noradrenalin, dopamine, and serotonin of
WT, BSKO, and SIRT1 OX mice. BSKO mice had significantly
higher levels of serotonin (Figure 2A) and noradrenalin (Figure 2B)
than their WT littermates, but no significant difference in the
levels of dopamine (Figure 2C) was detected. Additionally,
BSKO animals had significantly lower levels of 5-hydroxyindole-
acetic acid (5-HIAA, Figure 2D). SIRT1 OX mice had reciprocal
levels of serotonin and 5-HIAA compared to BSKO—lower levels
of serotonin and higher levels of 5-HIAA (Figures 2E–2H). Similar
findings were made in subsections of the brains obtained by
dissection (Figures S2A–S2J).
5-HIAA is an oxidation product of serotonin (Aklillu et al., 2009),
and MAO-A is the major enzyme in the brain that converts sero-
tonin into 5-HIAA (Figure 2I). Treatment of WT animals with the
MAO-A inhibitorphenelzine resulted inasimilarpatternofchanges
of serotonin (Figure 2J) and 5-HIAA (Figure 2K) as in BSKO brains.
Our findings therefore suggest that there is diminished MAO-A
activity in BSKO mice and elevated MAO-A activity in SIRT1 OX
mice. We verified this hypothesis by directly measuring specific
MAO-A activity in the mitochondrial extract (Hampp et al., 2008)
from the whole brains of BSKO animals and their WT littermates
and found a 12.45% decrease (p = 0.0059) in specific MAO-A
activity in brains of SIRT1 knockout animals (Figure S2K).
MAO-A Transcription Is Controlled by SIRT1 In Vivo
and In Vitro
To further address how SIRT1 controls MAO-A, wemeasured by
SDS-PAGE the abundance of this enzyme in the brains of WT
and mutant mice. BSKO mice had lower levels of MAO-A in their
brains (Figures 1A, S1H, and S1I), whereas SIRT1 OX mice had
higher levels (Figures 1A and S1J). It is known that the amygdala
is a part of the brain particularly involved in anxiety and mood
modulation, therefore we also measured abundance of MAO-A
in this region and again found that SIRT1 OX mice had higher
levels of MAO-A protein and BSKOmice had lower levels relative
to WT littermates (Figure S2L).
MAO enzymes are mitochondria-bound proteins, whereas
SIRT1 is generally nuclear (Prozorovski et al., 2008), suggesting
that SIRT1 regulates MAO-A abundance at the level of transcrip-
tion. Quantitative real-time PCR analysis showed that MAO-A
mRNA abundance is lower in brains of BSKO mice (Figure 2L)
and higher in brains of SIRT1 OX mice (Figure 2M) compared
to their WT littermates. We obtained similar results for the amyg-
dala (Figure S2M). These experiments suggested that SIRT1 is
an activator of MAO-A transcription in vivo. To further confirm
this hypothesis, we performed chromatin immunoprecipitation
(ChIP) experiments and found that SIRT1 binds to the MAO-A
promoter in close proximity to the ATG start codon but not to
a region 2 kilobases (kb) upstream (Figure 3A). To demonstrate
the specificity of the ChIP experiment, we performed identical
experiments in SIRT1 null mice and found no enrichment by
SIRT1 antibody of any DNA regions (Figure 3A).
To begin to study the mechanism by which SIRT1 activates
transcription of MAO-A, we transfected mouse neuroblastoma
cells (N2A) with a plasmid that expresses human SIRT1 via
the CMV promoter. Note that human SIRT1 is slightly
larger than endogenous mouse SIRT1, giving rise to a slower-
migrating band on the western blot (Figure 3B). A MAO-Aell 147, 1459–1472, December 23, 2011 ª2011 Elsevier Inc. 1461
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Figure 2. SIRT1 Regulates Levels of Neurotrans-
mitters
(A and B) BSKO mice have higher levels of (A) serotonin
and (B) noradrenalin in the brain than their littermates.
(C) Dopamine is not statistically different in BSKO mice.
(D) BSKO mice have lower levels of 5-HIAA.
(E–G) SIRT1 OX mice have lower serotonin (E) and similar
noradrenalin (F) and dopamine (G).
(H) SIRT1 OX mice have higher levels of 5-HIAA.
(I) MAO-A is the major enzyme in the brain that converts
serotonin into 5-HIAA.
(J and K) Phenelzine (MAOI) treatment increases serotonin
(J) and decreases serotonin degradation product 5-HIAA
(K) levels in the brains of WT mice, similar to the effect of
SIRT1 deletion.
(L and M) RT-PCR indicates lower levels of MAO-A mRNA
in the brains of BSKO mice (L) and higher levels in SIRT1
OX mice (M).
(A–H and J–M) Data presented as mean ± SEM. p values
are calculated using t test. See also Figure S2.promoter-luciferase construct (Hampp et al., 2008) was trans-
fected simultaneously with the SIRT1-overexpressing plasmid
or a control lacZ-expressing plasmid, revealing that enforced
expression of SIRT1 activated transcription of luciferase (Fig-
ure 3B). In order to reduce SIRT1 function, we expressed short
hairpin RNAs targeted against SIRT1 and observed a decline in
MAO-A promoter activity as compared to a scrambled control
shRNA (Figure 3C). These data further indicated that SIRT1
directly regulates activity of the MAO-A promoter.
To investigatewhether enzymatic activity of SIRT1 is important
for its ability to activate the MAO-A promoter, we expressed a
mutant SIRT1 allele, where histidine at position 363 is substituted
for tyrosine (H363Y), which reduces the enzymatic activity (Pfis-
ter et al., 2008). We observed that this mutation also reduced the
ability of SIRT1 to activate the MAO-A promoter (Figure 3D and
Table S2), suggesting that SIRT1 enzymatic activity is required
for complete activation of the MAO-A promoter.
NHLH2 Is Deacetylated by SIRT1 to Activate Expression
of MAO-A
The MAO-A-luciferase reporter contained a promoter sequence
extending 1.1 kb upstream of the MAO-A translation start site1462 Cell 147, 1459–1472, December 23, 2011 ª2011 Elsevier Inc.(Hampp et al., 2008), so we hypothesized that
one of the transcription factors that binds to
this sequence is likely the target of SIRT1. To
define the SIRT1-responsive promoter region,
we first cloned four overlapping 300 bp subsec-
tions of the original 1.1 kb promoter into the lucif-
erase vector and transfected each construct
into N2A cells with normal, knocked down, or
overexpressed SIRT1 (Figure 4A, left panel).
Consistent with ChIP, the most ATG-proximal
300 bp fragment displayed full promoter activity
and SIRT1 responsiveness. Next we subcloned
four overlapping 90 bp subregions of this
300 bp fragment into the luciferase reporter
and tested activity and SIRT1 responsivenessin N2A cells (Figure 4A, right panel, Figure 4B). The two middle
and overlapping 90 bp fragments had the strongest signal, as
well as responsiveness to SIRT1. Using bioinformatics tools
(Marinescu et al., 2005), we searched for transcription factors
that could bind these pieces of DNA and identified two sites for
NHLH1 and NHLH2 (Brown et al., 1992) (Figure 4B), which are
related brain-specific helix-loop-helix transcription factors
(Brown et al., 1992) (Figure S3A). Both NHLH2 (Coyle et al.,
2002; Good et al., 2008) knockout mice and BSKO (Cohen
et al., 2009) mice show changes in physical activity consistent
with the possibility that NHLH2 is a SIRT1 target.
We thus generated a series of artificial luciferase reporter
constructs containing repeats of CGCAGCTGCG (NHLH2
consensus-binding sequence, Figure S3A). Although this
construct was SIRT1 responsive, its activity was rather low.
Interestingly, the 90 base SIRT1-responsive fragments also
contained binding sites of the ubiquitous transcription factor
SP1, and incorporation of synthetic SP1-binding sites between
NHLH2 sites created a potent promoter, which responded
more strongly to SIRT1 (Figure 4C). SP1 sites alone were not
sufficient to provide responsiveness to SIRT1 (Figure 4C and
Tables S3A–S3D).
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Figure 3. SIRT1 Directly Activates MAO-A Transcription
(A) Chromatin immunoprecipitation reveals the presence of SIRT1 on the MAO-A promoter-proximal DNA but not 2 kb upstream or anywhere in SIRT1 null mice.
Data presented as mean ± SEM. p values are calculated using t test.
(B) SIRT1 overexpression activates MAO-A transcription as measured by a luciferase reporter.
(C) Knockdown of endogenous SIRT1 by short hairpin RNA reduces MAO-A transcription.
(D) SIRT1 enzymatic activity is required for its ability to activate the MAO-A promoter. The H363Y mutation largely suppresses ability to activate MAO-A tran-
scription (Table S2 presents complete statistical analysis of data shown using ANOVA).
(B–D) Box-plots present median, 25th, and 75th percentiles of data. Whiskers present 5th and 95th percentiles of data, with actual data points on the right.
p values are calculated using t test.To confirm that NHLH2 is indeed a bona fide transcriptional
factor that responds to SIRT1 on the MAO-A promoter, we
mutated both NHLH2 sites in the 1.1 kb MAO-A promoter by
substituting eight bases in each NHLH2-binding site with a string
of adenosines, so that spatial relationships in the promoter were
not disturbed, and found that the resulting mutant promoter lost
activity and responsiveness to SIRT1 (Figure 4D).
The hypothesis that SIRT1 acts on NHLH2 to modulate
MAO-A activity predicts that SIRT1 and NHLH2 would interact
physically or at least be part of the same molecular complex.
To verify this, we performed a series of coimmunoprecipitationC(co-IP) experiments (Figures S3B–S3E). We first immunoprecip-
itated NHLH2 from the brain tissue of WT mice and found that
SIRT1 coprecipitates with it (Figure S3B). Reciprocally, when
SIRT1 was immunoprecipitated from the mouse brain lysate,
NHLH2 coprecipitated with it (Figure S3C).
We next coexpressed humanmyc-tagged NHLH2 and human
V5-tagged SIRT1 in N2A cells and found that these proteins also
coimmunoprecipitate (Figures S3D and S3E). Additionally, we
found that expressing human myc-tagged NHLH2 activated
the 1.1 kb MAO-A promoter by about 5-fold (Figure S4A, see
also Figure 5D, second lane). At these high levels of NHLH2,ell 147, 1459–1472, December 23, 2011 ª2011 Elsevier Inc. 1463
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Figure 4. Identification of NHLH2 Sites as SIRT1 Response Elements in the MAO-A Promoter
(A) Fragmentation of the MAO-A promoter identified candidate transcriptional factors that may be regulated by SIRT1. The 1.1 kb MAO-A promoter was
segmented into four 300 bp fragments and cloned in front of luciferase. Only the most ATG-proximal fragment had promoter activity as well as SIRT1
responsiveness (left panel). This 300 bp fragment was segmented into four 90 bp overlapping fragments, with the two middle fragments possessing promoter
activity and SIRT1 responsiveness (right panel). Mean ± SEM is shown.
(B) Bioinformatics identifies NHLH1/2 sites in the 90 bp SIRT1-responsive fragments. See also Figure S3A.
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overexpression of SIRT1 did not further activate the MAO-A
promoter (Figure S4B), suggesting that NHLH2 and SIRT1 acti-
vate MAO-A via the same pathway.
We proceeded to study the mechanism by which SIRT1 regu-
lates NHLH2 activity on the MAO-A promoter. First, we investi-
gated the acetylation status of NHLH2 in vivo. We found that
NHLH2 is hyperacetylated in the brains of BSKOmice and hypo-
acetylated in the brains of SIRT1 OX mice as compared to
corresponding WT littermates (Figure 5A), providing further
evidence that SIRT1 deacetylates NHLH2 and thus increases
its transcriptional activity. We next purified human NHLH2-myc
from N2A cells, as well as cells that either overexpressed
SIRT1 or had SIRT1 suppressed by shRNA or nicotinamide,
and subjected it to liquid chromatography-tandem mass spec-
trometry (LC-MS/MS). We found that a single residue, K49,
was acetylated (Figures 5B and 5C), but only when the activity
of SIRT1 was suppressed by shRNA or nicotinamide—no acety-
lation of NHLH2 was detected in samples from cells that overex-
pressed SIRT1 or in control cells. It should be noted that this
experiment was repeated three times, and similar numbers of
counts for the tryptic peptide containing K49 were detected for
each sample. These data show that NHLH2 can be acetylated
on K49, and that SIRT1 is capable of deacetylating this residue.
We next expressed human NHLH2 with K49 mutated to argi-
nine (K49R) or glutamine (K49Q) and investigated the activity of
these mutant transcription factors on the 1.1 kb MAO-A
promoter (Figure 5D). WT NHLH2 upregulatedMAO-A transcrip-
tion almost 5-fold, but K49R and K49Q mutants only 4- and
3-fold, respectively (Figure 5D), suggesting that K49 is an impor-
tant residue for determining NHLH2 activity on the MAO-A
promoter. Critically, we found that reduction of SIRT1 abun-
dance by shRNA decreased activity of WT NHLH2 by 57%.
However, the same reduction of SIRT1 resulted in only a 14%
activity reduction of K49Q mutant and a 28% reduction in the
K49R mutant (Figure 5D). These results suggest that deacetyla-
tion of K49 by SIRT1 regulates NHLH2 activity. The residual
response that is observed in K49 mutants may indicate that
a minor component of NHLH2 activation occurs through binding
of SIRT1 or deacetylation at secondary sites.
To further prove that SIRT1 directly deacetylates NHLH2, we
performed in vitro acetylation/deacetylation assays. After codon
optimization, we expressed and purified recombinant GST-
SIRT1 from bacterial host designed for protein expression. We
also expressed and purified NHLH2-myc (WT and K49R mutant)
from N2A cell culture. First we in vitro acetylated NHLH2 with the
HAT domain of p300 (Figure 5E, lanes 4 and 5, as compared to
unacetylated NHLH2, lanes 2 and 3). WT protein was more acet-
ylated as compared to the K49 mutant (compare lanes 4 and 5),
indicating that K49 is a major site of acetylation in vitro (but not
the only site). After washing and repurification of acetylated
NHLH2, we subjected these molecules to recombinant SIRT1
(Figure 5E, lanes 6 and 7). WT NHLH2 was deacetylated to(C) Artificial promoters of five repeats of the NHLH2-binding site show SIRT1 res
potent promoter also responsive to SIRT1. The promoter with SP1 sites only is no
analysis of data presented here.
(D) The full-length MAO-A promoter with mutated NHLH2-binding sites loses ac
(C and D) Data presented as mean ± SEM. p values are calculated using t test a
Ca much higher degree than the K49R mutant (on Figure 5E,
compare the large decrease in acetylation between lanes 4
and 6 for WT with the smaller change in acetylation between
lanes 5 and 7 for K49R). These data further supported the claim
that SIRT1 directly deacetylates NHLH2 on K49, which activates
its transcriptional activity on the MAO-A promoter to cause
changes in behavior.
SNPs in the SIRT1 Gene Are Associated with Risk
of Anxiety in Humans
To determine whether SIRT1 is associated with psychiatric
disorders in humans, we genotyped 14 single-nucleotide poly-
morphisms (SNPs) encompassing the SIRT1 gene in a random
sample of 3,420 men and women between the ages of 35 and
66 from the City of Lausanne, Switzerland (PsyCoLaus study;
Preisig et al., 2009). All participants were assessed using a semi-
structured interview (Nurnberger et al., 1994), and diagnoses
were assigned according to DSM-IV (American Psychiatric
Association, 1994). Participants also completed the Trait
Subscale of the State-Trait Anxiety Inventory (STAI) (Spielberger
et al., 1970), which provides ameasurement of the overall level of
persistent anxiety. We tested SNPs in SIRT1 for association with
specific anxiety disorders, the overall level of anxiety, and
depression (Figures 6A–6D). We observed association between
SNPs in SIRT1 and any anxiety disorder (rs10997870), panic
disorder (rs12778366 and rs10997870), and social phobia
(rs12778366), which survived both Bonferroni and permuta-
tion-based (n = 10,000 permutations) multiple testing corrections
(pcorrected < 0.05). A trend of association was also observed
between rs12413112 and major depressive disorder; however,
this result did not survive Bonferroni correction (Figure 6D).
We attempted to replicate our strongest human association
finding for this gene, SNP rs10997870 with the specific anxiety
phenotype of panic disorder, in a comparable independent
sample. The Virginia Adult Twin Study of Psychiatric and
Substance Use Disorders (VATSPSUD) is a longitudinal commu-
nity study of over 9,000 adult Caucasian twins born in Virginia
(Kendler et al., 2001). Lifetime psychiatric diagnoses were ob-
tained via face-to-face or telephone-administered psychiatric
interviews based on the Structured Clinical Interview for DSM-
III-R (SCID) (Spitzer et al., 1992). We genotyped rs10997870
using the TaqMan method (Livak, 1999) in 1,398 independent
subjects from a subset of the VATSPSUD previously selected
for molecular genetic studies based upon genetic risk for
internalizing disorders (Hettema et al., 2008). Among these, we
identified 117 subjects with lifetime panic disorder (the cases)
and 675 controls with no lifetime mood or anxiety disorders for
analysis. Case-control analysis revealed a predisposing associ-
ation between rs10997870 (the G allele as in the Lausanne study)
and risk of panic disorder (freq.[cases] = 0.397, freq.[controls] =
0.329, c2 = 4.182, p = 0.041), confirming our initial discovery
(Figure 6D).ponsiveness. NHLH2 sites interspersed with SP1-binding sites create a more
t responsive to SIRT1 (top construct). See also Table S3 for complete statistical
tivity and responsiveness to SIRT1.
nd ANOVA (* denotes p < 0.05). See also Figure S3.
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Figure 5. NHLH2 Can Activate MAO-A, and Lysine 49 of NHLH2 Is Deacetylated by SIRT1
(A) Left panel, NHLH2 is hyperacetylated in brains of BSKO mice and hypoacetylated in brains of SIRT1 OX mice. Typical SDS-PAGE is shown. Immunopre-
cipitated NHLH2 from brain lysates of WT and transgenic mice was probed with anti-NHLH2 antibody (loading control) or anti-Ac-K antibody. Each lane
represents one mouse, and three mice of each genotype were tested. Right panel, quantification of the data presented in the left panel. Blots were quantified
using the densitometry function in Image-J, NIH. At least three animals were used per genotype. * denotes p < 0.05, ** denotes p < 0.01. Intensity of Ac-K bands
was normalized to intensity of NHLH2 bands, and all the data were normalized to WT signal strength. Mean ± SEM is shown.
(B) Tandem mass spectrometry (LC-MS/MS) analysis of NHLH2 identified lysine 49 to be acetylated (K49). Typical ion fragmentation diagram is presented.
Fragment ions were consistent with acetylation at site K49 with ion series shifting by 42 Da starting at b19 from the N terminus of the peptide and y5 from the
C terminus, which corresponds to acetylation of K49.
(C) Acetylated peptides on K49 are also resistant to Trypsin digestion. K49 was the only acetylated residue we identified. The experiment was repeated three
times, and an identical number of acetylated peptide counts was identified for each sample.
(D) NHLH2 overexpression (left two lanes) activates 1.1 kb MAO-A promoter in N2A; also see Figure S4A. K49 residue was mutated to arginine (K49R) or
glutamine (K49Q), and these mutant proteins or lacZ were expressed in N2A cells also transfected with a control shRNA (Scr) or a SIRT1 shRNA (shRNASirt1).
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A recent independent study conducted in Japanese subjects
provides confirmatory evidence for our findings (Kishi et al.,
2010). In this Japanese study, an association between another
SIRT1 SNP, rs10997875, and major depressive disorder was
observed. This is relevant because the SIRT1 SNP showing
association in our study (rs10997870) is in strong linkage
disequilibrium (LD) with rs10997875 in both Japanese (R2 =
96) and European (R2 = 93, Figure 6E) populations (Thorisson
et al., 2005), thereby providing additional evidence for an asso-
ciation between a SIRT1 haplotype encompassing these SNPs
and psychiatric disorders. Further proof of a role for SIRT1 in
mood regulation in humans was provided recently by Abe
et al. (2011), who showed that expression levels of SIRT1 in
white blood cells are associated with certain mood disorders.
To further explore the relationship betweenSIRT1 genetic vari-
ation and mood disorders, we sequenced SIRT1 exons in the
1,952 individuals from the PsyCoLaus study and investigated
rare nonsynonymous (amino acid-changing) variants for associ-
ationwith anxiety.We found that carriers of rare nonsynonymous
variants in SIRT1 (Figure S5A) were more likely to have ‘‘any
anxiety disorder’’ (panic disorder, agoraphobia, social phobia,
or generalized anxiety disorder; with 43.1% of carriers having
an anxious phenotype compared to 31.6% of the group as
a whole; p = 0.015; Figure S5B). It is noteworthy that the majority
of nonsynonymous mutations were located in the C’ or N’
terminus of the protein (Figure S5A) far from the catalytic domain,
suggesting that the mutations may decrease interaction with
another protein such as the inhibitor DBC1 (Kim et al., 2008;
Zhao et al., 2008) or destabilize an internal negative regulatory
domain. To investigate themechanistic link between thesemuta-
tions and SIRT1 activity, we introduced two of the most frequent
mutations in theN terminus (S14P andP37L) into our overexpres-
sionplasmid and tested the ability of these twomutant proteins to
activate theMAO-A-luciferase reporter.We found that bothS14P
andP37L SIRT1mutant proteins (Figure 6F) had enhanced ability
to activate MAO-A compared to WT (Figure 6G). We also tested
activity of S14P and P37L mutants in vitro. Indeed, recombinant
SIRT1 enzyme (Figure S5C) with S14P and P37L mutations had
increased activity compared toWT (Figure S5D). These data rein-
force the hypothesis that SIRT1 controls anxiety andmood disor-
ders in humans, and that the mechanism of this control might be
similar to the one we described in rodents.
DISCUSSION
We show that brain SIRT1 influences anxiety and behavior and
describe a mechanism for this effect (Figure S6A). SIRT1 drivesSDS-PAGE blots show SIRT1 knockdown in cells (right three treatments). Activa
reduces activity of WT NHLH2 by 57% (*p = 1.46$1011), whereas activities of K4
respectively. Box-plots present median, 25th, and 75th percentiles of data. Whisk
p values are calculated using t test.
(E) Left panel, anti-acetyl lysine blot showing SIRT1 deacetylation of K49 of NHLH
myc beads, washed, and acetylated with the HAT domain of p300 (lanes 4 and 5
NHLH2, purified GST-SIRT1 (from E. coli) was added (lanes 6 and 7). WT NHLH2w
decrease in acetylation between lanes 4 and 6 for WT to the smaller change in ace
presented on the left panel. Blots were quantified using the densitometry function
bands. Mean ± SEM is shown.
Canxiety-like behavior and inhibits exploratory behavior in mice
by deacetylating the brain-specific transcription factor NHLH2
on lysine 49, which increases its activity on the MAO-A
promoter. Because MAO-A degrades serotonin, increases in
MAO-A reduce levels of this neurotransmitter, leading to
anxiety and depression (Nordquist and Oreland, 2010). Indeed
MAO-A inhibitors normalize anxiety differences in mice with
altered levels of brain SIRT1. Genetic analyses of human
SIRT1 polymorphisms in independent cohorts of people
suggest that the role of this sirtuin in modulating anxiety and
mood is conserved.
It is intriguing that SIRT1 may link nutritional status of animals
to their behavior. Over the course of evolution, animals have
faced variable periods of food availability, and the ability to
respond to these fluctuations would be selected for. Below we
discuss two scenarios, one short term (typical calorie restriction,
CR) and the other long term (acting on intergenerational time-
scales), to demonstrate the benefit of having mood and explor-
atory drive regulated by food availability.
CR is known to increase physical activity in laboratory rodents
in their home cages (Weed et al., 1997), and SIRT1 in the brain
appears to be at least partially responsible for this increase
(Chen et al., 2005). Although CR was reported not to change
anxiety of rodents (Minor et al., 2008), we reinvestigated this
using the more sensitive zero-maze paradigm and found CR
mice (Figures 7A and 7B) to bemore anxious than their ad libitum
fed littermates (Figures 7C and 7D). The increase in activity
observed in home cages has been interpreted to represent
an increase in the urge to forage. However, we observed
that CR mice traveled distances similar to those of ad libitum
counterparts inside the zero-maze apparatus (Figure 7E). We
suggest that the major behavioral impact of CR is to increase
anxiety, perhaps to protect animals during foraging. The previ-
ously observed increase in activity in home cages may actually
reflect this heightened anxiety-like state.
To address long-term food scarcity, we now consider the clas-
sical three-species food chain, described by the Lotka-Volterra
model (Figures 7F and S6B). The number of species (food,
species of interest [e.g., mice], and predators of that species)
will oscillate in the order depicted on Figure 7F (also see Fig-
ure S6). The rise of food will be followed by the rise of the species
of interest, followed by the rise of predators of that species. The
ability to navigate these cycles and dynamically adapt will be
strongly selected for in the species of interest. This cycle (Fig-
ure 7F) can be roughly split in two halves: On the left, food is
abundant, the population of the species of interest increases,
and predation is low (Figure 7F, green shaded area). On the right,tion of 1.1 kb MAO-A promoter in N2A cells shows that knockdown of SIRT1
9Q and K49R are reduced by 14% (*p = 8.33$104) and 28% (*p = 4.04$104),
ers present 5th and 95th percentiles of data, with actual data points on the left.
2 in vitro. Purified recombinant NHLH2-myc (from N2A cells) was bound to anti-
, as compared to lanes 2 and 3). After washing and repurification of acetylated
as deacetylated to amuch higher degree than K49Rmutant (compare the large
tylation between lanes 5 and 7 for K49R). Right panel, quantification of the data
in Image-J, NIH. Intensity of Ac-K bands was normalized to intensity of NHLH2
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Figure 6. Genetic Variants in the SIRT1 Gene Are Associated with Risk of Anxiety in Humans
(A–C) Regional association (log10 of the p value) plot for SNPs in the SIRT1 gene region for any anxiety disorder (A), panic disorder (B), and major depressive
disorder (C). Physical positions for each of the 14 SNPs tested, the SIRT1 gene (arrows depicting direction of transcription), and HERC4, a neighboring gene, are
shown (International HapMap Consortium, 2003, release #28). The SNPwith the best association is denoted by a red square. The best association for any anxiety
disorder was observed with SNP rs10997870, for panic disorder with SNP rs12778366, and for major depressive disorder with SNP rs12413112.
(D) A summary of the associations between SNPs in SIRT1 and anxiety disorders and depression in humans, in three independent population-based cohorts of
people (from Europe, USA, and Japan; Kishi et al., 2010; also see Figure S5). The trait, SNP ID and position, minor allele frequency (MAF), allele frequency in
cases, allele frequency in controls, t-statistic coefficient (Stat), nominal p value (p), Bonferroni-corrected p value (Bonf. P), and permutation-based corrected p
value (Permut. P, N = 10,000) are presented. PsyCoLaus cases from Lausanne (Preisig et al., 2009) were white Caucasians who met the criteria for any of the
following: agoraphobia (n = 122), generalized anxiety disorder (n = 62), panic disorder (n = 92), social phobia (n = 342), post-traumatic stress disorder (n = 133), or
depression (n = 1255). Controls were Caucasians who did not meet criteria for any of these disorders. Cases for the Virginia Study (Hettema et al., 2008) were
adults who met criteria for panic disorder (n = 117). Note that rs10997870 is in strong LD with rs10997875 in Europeans and Japanese populations (E).
(E) LD evaluation of common SNPs in SIRT1. ATG denotes the SIRT1 translation start codon, vertical bars represent SIRT1 exons, and TAG denotes the stop
codon. Shaded diamonds depicting LD betweenmarkers (black shading represents complete LD, andwhite shading, no LD) are based on the R2measure, where
a value of ‘‘93’’ corresponds to R2 = 0.93. Note, a number of SNPs showing nominal association (p% 0.05) with mood disorders in this study are in moderate to
strong LD.
(F) We duplicated two of the most frequent mutations in the N terminus of SIRT1 (S14P and P37L, see Figures S5A, S5C, and S5D) in our overexpression plasmid.
SDS-PAGE blot is shown to demonstrate overexpression of mutant human SIRT1 proteins in N2A cells.
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food is scarce, the population of the species of interest drops,
and predation is high (Figure 7F, red shaded area). Food abun-
dance suppresses SIRT1 activity in many regions of the brain
(Chen et al., 2008), including the amygdala (Figures 7G and
7H), resulting in increased exploratory drive and reduced
anxiety. This strategymakes sense because a time of food abun-
dance and low predation would be propitious for radiation of the
species. Alternatively, food scarcity will activate SIRT1 (Figures
7G and 7H), increasing anxiety and decreasing exploratory drive.
This strategy also makes sense because a time of food scarcity
and high predation would behoove high vigilance, as discussed
for CR above. In this regard, it is fascinating that nursingmothers
put on calorie restriction have been reported to yield pups that
have a suppressed exploratory drive no matter how they are
fed later in life (Frankova´ and Barnes, 1968). In summary,
SIRT1 may trigger psychological changes to complement its
known effects on stress-response pathways to ensure longer
survival in adverse conditions.
Conclusion
Here we describe a mechanism by which SIRT1 in the brain
directly regulates mood and behavior by deacetylating the
NHLH2 transcription factor that activates MAO-A transcription.
In addition, unbiased human-based population studies revealed
that both common and rare variants in SIRT1 are associated with
anxiety and other psychiatric disorders. These data provide
evidence for the role of SIRT1 in modulating mood and behavior,
which will help guide the development of brain-permeable SIRT1
drugs for psychiatric and neurodegenerative diseases. Addition-
ally, we describe a theoretical evolutionary model for adaptation
of a species to food availability and predation that helps ratio-
nalize the link between SIRT1 and anxiety. Foraging-predation
risk trades-offs strongly influence evolution and define ecosys-
tems, and nutrient-sensing enzymes such as SIRT1 may directly
orchestrate these events by exerting psychological, as well as
physiological, effects.
EXPERIMENTAL PROCEDURES
Mice and Behavioral Tests
All procedures were performed according to guidelines and under supervision
of the Committee for Animal Care (CAC) of Massachusetts Institute of Tech-
nology. For all tests, we used 3-month-old animals. All mutants were
compared to corresponding WT littermates. Males were single housed and
handled daily for 2 weeks prior to the test to eliminate the influence of hierarchy
on their behavior and to minimize anxiety due to human handling. In all tests,
animal behavior was filmed and analyzed later with the help of custom-written
software.
Where applicable, intraperitoneal injections of 20 mg/kg of body weight of
phenelzine or fluoxetine were given to eachmouse every other day for 2 weeks
and 1 hour prior to each behavior test.
RT-PCR
cDNAwas prepared using RetroScript (Ambion) as permanufacturer’s instruc-
tions. Abundance of specific RNA in samples was normalized to ribosomal(G) S14P and P37L SIRT1mutant proteins had enhanced ability to activateMAO-A
an enhanced activity of SIRT1 in the brains of these subjects might increase their s
(also see Figures S5C and S5D). Box-plots represent median, 25th, and 75th per
data points on the right. p values are calculated using t test.
Cprotein rpl19. RT-PCR was performed using the Roche 480 system, with the
following primers: MAO-A-F: GCCCAGTATCACAGGCCAC;MAO-A-R: CGGG
CTTCCAGAACCAAGA; rpl19-F: ATGAGTATGCTCAGGCTACAGA; rpl19-R:
GCATTGGCGATTTCATTGGTC.
LC-MS/MS
After in-gel digestion of samples with trypsin, they were analyzed using
reversed phase microcapillary LC-MS/MS. It was performed using an
EASY-nLC nanoflow HPLC (Proxeon Biosciences) with a 75 mm id 3 15 cm
C18 column connected to a hybrid LTQ linear ion trap-Orbitrap XL mass
spectrometer (Thermo Fisher Scientific) in data-dependent acquisition and
positive ion mode at 300 nL/min followed by protein database searching
using Sequest.
Plasmids
MAO-A-luciferase reporter plasmid was a generous gift from U. Albrecht and
has been described previously (Hampp et al., 2008). Luciferase activity was
measured using the Dual-Luciferase Reporter Assay System (Promega) with
Renila as the reference. The plasmid encoding human NHLH2 was purchased
from OriGene (TrueORF collection). Detailed methods can be found in
Extended Experimental Procedures.
Genetic Analysis
Genotyping of SIRT1 tag-SNPs was conducted by KBioscience (http://www.
kbioscience.co.uk/), and DNA sequencing was performed by Agencourt
Biosciences using capillary sequencing on genomic DNA samples from
a subset of the PsyCoLaus population-based cohort from Lausanne,
Switzerland.
Statistical Analysis
Unless otherwise noted, results are expressed as mean ± standard error of the
mean (SEM). Differences between two groups (‘‘cases’’ and ‘‘controls’’) were
assessed with unpaired two-tailed t tests. The Extended Experimental Proce-
dures contain detailed statistical analysis of all experiments using t test, u test,
Kruskal-Wallis, and ANOVA where applicable. For the PsyCoLaus human
association studies, we used stringent quality-control criteria, requiring
Hardy-Weinberg p values >107, <30% missing data per SNP, <10% missing
data per individual, and an SNPminor allele frequency >0.01. In each analysis,
the regression was carried out including age, sex, and the first two genotype
principal components as covariates. Analysis was carried out in PLINK (Clarke
et al., 2011) using a logistic regression. The permutation tests were carried out
using 10,000 permutations in PLINK.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and three tables and can be found with this article online at doi:10.
1016/j.cell.2011.10.054.
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Figure 7. Evolutionary Theory Explains Advantages of Anxiety Control by Food Availability
(A and B) Calorie-restricted (CR) mice have lower body weight (A) and lower blood glucose (B). Box-plots represent median, 25th, and 75th percentiles of data.
Whiskers present 5th and 95th percentiles of data, with actual data points on the left. p values are calculated using t test.
(C and D) CRmice are more anxious and explore less in the zero-maze than their counterparts fed ad libitum diet. Typical tracking diagrams (C) are shown for CR
and ad libitum mouse. Mice were placed into zero-maze apparatus (see Figure 1B) always in the same position ‘‘start.’’ Behavior of animals was filmed, and their
movement was digitally tracked (Image-J, NIH). Upper and lower quadrants on the track-graph represent areas in the zero-maze that were protected bywalls (red
dots). Side quadrants of the graph represent open arms of the zero-maze (green dots). Fraction of time spent exploring (fraction of time spent on the open arms of
the maze) is quantified and presented (D). Mean ± SEM is shown.
(E) CR and ad libitummice have similar activity while inside the zero-maze. We find that CRmice travel a similar distance to that of ad libitum animals (E), yet they
explore less (D). Data presented as mean ± SEM. p values are calculated using t test.
(F) Evolutionary rationale for mood regulation by SIRT1 (also see Figure S6). In the three-species food chain, the population sizes will oscillate as shown. In the left
part of the cycle (green shaded area), food abundance is high (rendering SIRT1 activity low) and predation is low, which suggest that low anxiety and high
exploration is the best strategy. In the right part (red shaded area), food is scarce (rendering SIRT1 activity high) and predation is high, suggesting that minimal
exploration with maximum vigilance is the best strategy.
(G) Animals subjected to CR have more SIRT1 in amygdala obtained by microdissection. SDS-PAGE for SIRT1 is presented, with tubulin as loading control.
(H) Quantification of data presented in (G) is shown using the densitometry function of Image-J software (NIH). Mean ± SEM is shown.
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